New nonabsorbable potassium-exchange resins in hyperkalaemia

Sara S. Roscioni, Hiddo Lambers Heerspink

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2 Citations (Scopus)

Abstract

New data suggest that treatment with patiromer or sodium zirconium cyclosilicate for up to 8 weeks reduces plasma potassium levels in hyperkalaemic patients. If proven safe and effective for long-term use, these therapies might be administered together with intensive renin-angiotensin-aldosterone blockade to reduce adverse effects and renal and cardiovascular risk.

Original languageEnglish
Pages (from-to)205-206
Number of pages2
JournalNature Reviews Nephrology
Volume11
Issue number4
DOIs
Publication statusPublished - Apr-2015

Keywords

  • TRIAL

Cite this